How well did we do? CBD-Intel’s predictions for 2021 reviewed

CBD-Intel was on point in its 2021 predictions. Much like the preceding year, we believed 2021 would largely be defined more by what did not happen than what did. We correctly predicted that there would be no movement in the clarification of the regulatory grey area CBD products found themselves in across multiple jurisdictions.

In the US, EU and UK there was no movement on the major issue – the legality of the use of CBD in ingestible products – and precious little movement on anything else.


Restricted content. Do you want to read more?